Hasil Pencarian - Sung‐Liang Yu
- Menampilkan 1 - 20 hasil dari 37
- Ke Halaman Berikutnya
-
1
MicroRNA and Pathogenesis of Enterovirus Infection oleh Bing-Ching Ho, Pan-Chyr Yang, Sung-Liang Yu
Diterbitkan 2016-01-01
Artikel -
2
-
3
Proteomic comparison of human embryonic stem cells with their differentiated fibroblasts: Identification of 206 genes targeted by hES cell-specific microRNAs oleh Zong-Yun Tsai, Chi-Hsien Chou, Chi-Yu Lu, Sher Singh, Sung-Liang Yu, Steven Shoei-Lung Li
Diterbitkan 2011-08-01
Artikel -
4
-
5
PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma. oleh Ay-Huey Huang, Szu-Hua Pan, Wen-Hsin Chang, Qi-Sheng Hong, Jeremy J W Chen, Sung-Liang Yu
Diterbitkan 2015-01-01
Artikel -
6
-
7
IKKε isoform switching governs the immune response against EV71 infection oleh Ya-Ling Chang, Yu-Wen Liao, Min-Hsuan Chen, Sui-Yuan Chang, Yao-Ting Huang, Bing-Ching Ho, Sung-Liang Yu
Diterbitkan 2021-06-01
Artikel -
8
Comparative Expression Profiles of mRNAs and microRNAs Among Human Mesenchymal Stem Cells Derived From Breast, Face, and Abdominal Adipose Tissues oleh Kai-Hung Wang, An-Pei Kao, Sher Singh, Sung-Liang Yu, Li-Pin Kao, Zong Yun Tsai, Sin-Daw Lin, Steven Shoei-Lung Li
Diterbitkan 2010-03-01
Artikel -
9
NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer. oleh Sheng-Tai Tzeng, Ming-Hong Tsai, Chi-Long Chen, Jing-Xing Lee, Tzu-Ming Jao, Sung-Liang Yu, Sou-Jhy Yen, Ya-Chien Yang
Diterbitkan 2013-01-01
Artikel -
10
Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. oleh Jen-Yi Lee, Yee-Ming Lee, Gee-Chen Chang, Sung-Liang Yu, Wan-Yu Hsieh, Jeremy J W Chen, Huei-Wen Chen, Pan-Chyr Yang
Diterbitkan 2011-01-01
Artikel -
11
A Celecoxib Derivative Eradicates Antibiotic-Resistant <i>Staphylococcus aureus</i> and Biofilms by Targeting YidC2 Translocase oleh Shiou-Ru Tzeng, Yi-Wei Huang, Yao-Qing Zhang, Ching-Yi Yang, Han-Sheng Chien, Yi-Ru Chen, Sung-Liang Yu, Ching S. Chen, Hao-Chieh Chiu
Diterbitkan 2020-12-01
Artikel -
12
MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. oleh Lu-Kai Wang, Tzu-Hung Hsiao, Tse-Ming Hong, Hsuan-Yu Chen, Shih-Han Kao, Wen-Lung Wang, Sung-Liang Yu, Ching-Wen Lin, Pan-Chyr Yang
Diterbitkan 2014-01-01
Artikel -
13
-
14
Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes oleh Chia-Ching Chang, Min-Shu Hsieh, Mong-Wei Lin, Yi-Hsuan Lee, Yi-Jing Hsiao, Kang-Yi Su, Te-Jen Su, Sung-Liang Yu, Jin-Shing Chen
Diterbitkan 2022-01-01
Artikel -
15
Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma. oleh Kang-Yi Su, Jeng-Sen Tseng, Keng-Mao Liao, Tsung-Ying Yang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Pan-Chyr Yang, Sung-Liang Yu, Gee-Chen Chang
Diterbitkan 2018-01-01
Artikel -
16
Extracorporeal Life Support Enhances the Forward Pressure Wave to Cause a Mismatch between Cardiac Oxygen Demand and Supply oleh Chih-Hsien Wang, Ru-Wen Chang, En- Ting Wu, Yi-Jing Hsiao, Ming-Shiou Wu, Hsi-Yu Yu, Yih-Sharng Chen, Liang-Chuan Lai, Sung-Liang Yu
Diterbitkan 2019-09-01
Artikel -
17
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M oleh Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Tsung-Ying Yang, Gee-Chen Chang
Diterbitkan 2021-08-01
Artikel -
18
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M oleh Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Tsung-Ying Yang, Gee-Chen Chang
Diterbitkan 2021-06-01
Artikel -
19
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients oleh Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Yen-Hsiang Huang, Gee-Chen Chang
Diterbitkan 2022-06-01
Artikel -
20